Kevin L. Winthrop
Centers for Disease Control and Prevention
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kevin L. Winthrop.
Clinical Infectious Diseases | 2004
Kevin L. Winthrop; Kim Albridge; David South; Peggy Albrecht; Marcy Abrams; Michael C. Samuel; Wendy Leonard; Joanna Wagner; Duc J. Vugia
Nontuberculous mycobacterial infections are becoming more common. Recently, Mycobacterium fortuitum and other rapidly growing mycobacteria have been found to cause severe skin and soft-tissue infections in association with nail salon whirlpool footbaths. We recently investigated a large outbreak of M. fortuitum furunculosis among women who received pedicures at a single nail salon. To better define the clinical course of such infections, we collected clinical details from physicians who were treating outbreak patients. We constructed multivariable linear models to evaluate the effect of antibiotic treatment on disease duration. Sixty-one patients were included in the investigation. The mean disease duration was 170 days (range, 41-336 days). Forty-eight persons received antibiotic therapy for a median period of 4 months (range, 1-6 months), and 13 persons were untreated. Isolates were most susceptible to ciprofloxacin and minocycline. Early administration of therapy was associated with shorter duration of disease only in persons with multiple boils (P<.01). One untreated, healthy patient had lymphatic disease dissemination.
Emerging Infectious Diseases | 2002
Puneet K. Dewan; Alicia M. Fry; Kayla F. Laserson; Bruce C. Tierney; Conrad P. Quinn; James A. Hayslett; Laura N. Broyles; Andi L. Shane; Kevin L. Winthrop; Ivan Walks; Larry Siegel; Thomas Hales; Vera A. Semenova; Sandra Romero-Steiner; Cheryl M. Elie; Rima F. Khabbaz; Ali S. Khan; Rana Hajjeh; Anne Schuchat
In October 2001, four cases of inhalational anthrax occurred in workers in a Washington, D.C., mail facility that processed envelopes containing Bacillus anthracis spores. We reviewed the envelopes’ paths and obtained exposure histories and nasal swab cultures from postal workers. Environmental sampling was performed. A sample of employees was assessed for antibody concentrations to B. anthracis protective antigen. Case-patients worked on nonoverlapping shifts throughout the facility. Environmental sampling showed diffuse contamination of the facility, suggesting multiple aerosolization events. Potential workplace exposures were similar for the case-patients and the sample of workers. All nasal swab cultures and serum antibody tests were negative. Available tools could not identify subgroups of employees at higher risk for exposure or disease. Prophylaxis was necessary for all employees. To protect postal workers against bioterrorism, measures to reduce the risk of occupational exposure are necessary.
Emerging Infectious Diseases | 2005
Duc J. Vugia; Yvonne Jang; Candi Zizek; Janet Ely; Kevin L. Winthrop; Edward Desmond
In 2000, an outbreak of Mycobacterium fortuitum furunculosis affected customers using whirlpool footbaths at a nail salon. We swabbed 30 footbaths in 18 nail salons from 5 California counties and found mycobacteria in 29 (97%); M. fortuitum was the most common. Mycobacteria may pose an infectious risk for pedicure customers.
American Journal of Ophthalmology | 2003
Kevin L. Winthrop; Ellen B. Steinberg; Gary P. Holmes; Marion A. Kainer; S.B. Werner; Andrea Winquist; Duc J. Vugia
PURPOSE To report national case-finding results for nontuberculous mycobacterial keratitis and describe its association with laser in situ keratomileusis (LASIK). DESIGN Enhanced passive disease reporting. METHODS In April 2001, we investigated a California cluster of Mycobacterium chelonae keratitis associated with hyperopic LASIK using a contact lens mask. To identify other possibly related cases, the American Academy of Ophthalmology e-mailed its members asking them to report recent cases of nontuberculous mycobacterial keratitis to the Centers for Disease Control and Prevention. RESULTS Forty-three additional cases of keratitis were reported (onsets between August 2000 and June 2001). Of these, 31 occurred as part of two unrelated LASIK-associated outbreaks. The 12 other reported cases occurred in sporadic fashion. Of the latter cases, 4 were associated with LASIK surgery. None of the reported cases were related to the M. chelonae cluster in California. CONCLUSIONS Laser in situ keratomileusis-associated keratitis with nontuberculous mycobacteria may be more common than previously known.
American Journal of Transplantation | 2004
Kevin L. Winthrop; Bernard M. Kubak; David A. Pegues; Catherine Hufana; Pam Costamagna; Ed Desmond; Cynthia A. Sanders; Paul Shen; Laura Flores-Ibarra; Eugene Osborne; David A. Bruckner; Jennifer Flood
Organ donors are not routinely screened for tuberculosis (TB) in the United States. We investigated a case of pulmonary TB in a double‐lung transplant recipient. We reviewed the donors and recipients records, and used molecular methods to compare the lung recipients isolate with others from three sources: her hospital, the California state health departments genotyping database, and the donors resident‐nation of Guatemala. A respiratory specimen obtained from the lung recipient 1 day after transplantation grew Mycobacterium tuberculosis. Donor chest radiograph had a previously unnoticed pulmonary opacity that was present on post‐transplant recipient chest radiographs and computed tomographs. The recipients isolate was molecularly distinct from others at her hospital and in the state database, but was identical to two isolates from Guatemala. Tuberculosis was transmitted from lung donor to recipient. As organ transplantation becomes more common worldwide, similar cases could occur. Screening for TB in potential organ donors should be considered.
The New England Journal of Medicine | 2002
Kevin L. Winthrop; Marcy Abrams; Mitchell A. Yakrus; Ira B. Schwartz; Janet Ely; Duncan Gillies; Duc Vugia
Arthritis & Rheumatism | 2005
Kevin L. Winthrop; Jeffrey N. Siegel; John A. Jereb; Zachary Taylor; Michael F. Iademarco
Emerging Infectious Diseases | 2006
Adi V. Gundlapalli; Michael A. Rubin; Matthew H. Samore; Bert K. Lopansri; Timothy Lahey; Heather L. McGuire; Kevin L. Winthrop; James J. Dunn; Stuart E. Willick; Randal L. Vosters; Joseph F. Waeckerle; Karen C. Carroll; Jack M. Gwaltney; Frederick G. Hayden; Mark R. Elstad; Merle A. Sande
Clinical Infectious Diseases | 2004
Kevin L. Winthrop; Jeffrey N. Siegel
International Journal of Tuberculosis and Lung Disease | 2005
Kevin L. Winthrop; James Scott; D. Brown; M. T. Jay; R. Rios; S. Mase; D. Richardson; A. Edmonson; M. MacLean; Jennifer Flood